Enfermedades pulmonares causadas por el tabaco: Parte 1 - mesa redonda del Día Mundial Sin Tabaco
World Health Organization (WHO)
9 min, 47 sec
This webinar marks World No Tobacco Day with discussions on the dangers of tobacco use and benefits of quitting, featuring experts Dr. Jane Rohini Oh Momo, Dr. Vin Gupta, and Dr. Havi Gouda.
Summary
- Tobacco is highlighted as a leading cause of death and disability, with chronic bronchitis and emphysema as common consequences.
- Secondhand smoke's risks, particularly to children and infants, are emphasized, with calls for smoke-free homes.
- The uncertain risks of new tobacco products, like e-cigarettes, are discussed, noting their appeal to youth and potential as a gateway to smoking.
- Available quitting aids such as counseling and medications are explored, with the importance of health professional guidance stressed.
- The immediate and long-term health benefits of quitting tobacco are outlined, including improved lung function and reduced cancer risk.
Chapter 1
The webinar begins with an introduction highlighting the global impact of tobacco on breathing and health, followed by an introduction of the host and panelists.
- The Director-General of the World Health Organization, Dr. Tedros, emphasizes the importance of a smoke-free day.
- Host Joel Schaeffer introduces the webinar and its focus on the harms of tobacco and quitting strategies.
- Health experts Dr. Jane Rohini Oh Momo, Dr. Vin Gupta, and Dr. Havi Gouda are introduced as panelists.
Chapter 2
Dr. Vin Gupta explains the severe health risks of tobacco use, including chronic bronchitis, emphysema, and the impact on both smokers and those exposed to secondhand smoke.
- Tobacco is the leading cause of death in men globally and second in combined genders since 1990.
- Chronic bronchitis and emphysema cause significant discomfort and reliance on inhalers and oxygen tanks.
- Secondhand smoke exposure increases the risk of asthma and other respiratory issues in children.
Chapter 3
The webinar addresses how respiratory diseases from tobacco degrade quality of life and the potential risks associated with new tobacco products like e-cigarettes.
- Tasks like walking or playing with grandchildren become difficult for those with tobacco-induced respiratory diseases.
- New tobacco products, including e-cigarettes, have uncertain risks and are appealing to youth, possibly leading to traditional smoking.
Chapter 4
Dr. Jane Rohini Oh Momo discusses the dangers of secondhand smoke, especially to children, and urges smoke-free environments.
- Secondhand smoke causes about 1 million deaths per year and particularly affects children's developing organs.
- Infants exposed to secondhand smoke have a higher risk of sudden infant death syndrome.
Chapter 5
The panelists discuss the various support options available for quitting tobacco, including counseling, medications, and the importance of professional health guidance.
- Counseling and medication treatments are more effective when combined for someone aiming to quit tobacco.
- Starting a conversation with a health professional is crucial in deciding the best quitting plan.
Chapter 6
Dr. Vin Gupta and Dr. Havi Gouda discuss the main barriers to quitting tobacco and the immediate and long-term health benefits of doing so.
- The primary barrier to quitting is access to mental health care during the lifestyle change process.
- Quitting tobacco leads to improved lung function within weeks and significantly reduces lung cancer risk within a decade.
Chapter 7
The webinar concludes with thanks to the panelists and an invitation to the audience to join the next webinar focusing on community and national tobacco control.
- The host thanks the panelists for their insights on the impacts of tobacco.
- An invitation is extended for the next webinar discussion on tobacco control.
More World Health Organization (WHO) summaries
Coronavirus disease (COVID-19)
World Health Organization (WHO)
A detailed exploration of the emergence, characteristics, spread, symptoms, diagnosis, treatment, and prevention of COVID-19.